GLP-1 Receptor Agonists → HbA1c
Semaglutide → HbA1c
Semaglutide shows strong improvement in HbA1c with consistent results (well-studied, 11 studies).
- EvidenceScore™
- 70
- ConsistencyScore™
- 89
Organizing diabetes research into clear, evidence-based insights powered by the Evidence Intelligence™ framework.
Understand diabetes research—without reading every study
| Intervention | Outcome | EvidenceScore™ |
|---|---|---|
| Tirzepatide | HbA1c | 70 |
| Semaglutide | HbA1c | 70 |
| Metformin | HbA1c | 62 |
Deep dives into key evidence areas with comprehensive research synthesis
Evidence related to lowering or improving HbA1c/A1C in diabetes management.
Evidence related to body weight reduction, BMI improvement, waist circumference, and body composition changes.
Evidence related to blood glucose control, fasting glucose, postprandial glucose, glucose variability, and time in range.
Evidence related to improving insulin resistance, insulin sensitivity, fasting insulin, C-peptide levels, and beta-cell function in diabetes and prediabetes.
Evidence related to preventing or delaying type 2 diabetes, reducing diabetes incidence, and improving metabolic risk in people with prediabetes.
Evidence related to diabetic kidney disease, albuminuria, kidney function, nephropathy progression, end-stage renal disease, and kidney-protective diabetes treatments.
Every study contributes evidence linking interventions and outcomes. deDiabetes organizes those findings into connected evidence topics so you can move from broad questions to supporting research.
Strongest findings from our evidence intelligence analysis
Semaglutide → HbA1c
Semaglutide shows strong improvement in HbA1c with consistent results (well-studied, 11 studies).
Tirzepatide → HbA1c
Tirzepatide shows strong improvement in HbA1c with consistent results (emerging research, 8 studies).
Semaglutide → Body weight
Semaglutide shows moderate improvement in Body weight with consistent results (well-studied, 10 studies).
Tirzepatide → Body weight
Tirzepatide shows strong improvement in Body weight with consistent results (emerging research, 7 studies).
Metformin → HbA1c
Metformin shows moderate improvement in HbA1c with consistent results (emerging research, 7 studies).
Vitamin D supplementation → Serum 25-hydroxyvitamin D
Vitamin D supplementation shows strong improvement in Serum 25-hydroxyvitamin D with consistent results (emerging research, 5 studies).
High-value evidence organized by EvidenceScore™, ConsensusScore™, and research focus
Highest-ranked evidence pairs currently in database
Evidence with agreement across multiple studies
Interventions with the broadest evidence base
Promising early-stage research areas
Recently published research
Recently added studies and evidence pairs
Highest-ranked intervention and outcome relationships from the evidence graph
Ranked using EvidenceScore™, validation, ConsensusScore™, and study depth
| # | Intervention | Outcome | Effectiveness | EvidenceScore™ | Studies |
|---|---|---|---|---|---|
| 1 | Tirzepatide | HbA1c | strong_positive | 70 | 0 |
| 2 | Semaglutide | HbA1c | strong_positive | 70 | 0 |
| 3 | Tirzepatide | Body weight | strong_positive | 67 | 0 |
| 4 | Semaglutide | Body weight | moderate_positive | 66 | 0 |
| 5 | Metformin | HbA1c | moderate_positive | 62 | 0 |
| 6 | Liraglutide | HbA1c | strong_positive | 61 | 0 |
| 7 | Dapagliflozin | HbA1c | moderate_positive | 60 | 0 |
| 8 | Tirzepatide | BMI | strong_positive | 60 | 0 |
| 9 | Semaglutide | BMI | moderate_positive | 55 | 0 |
| 10 | Vitamin D supplementation | HbA1c | moderate_positive | 55 | 0 |
| 11 | SMS text messaging behavioral intervention for health promotion | HbA1c | weak_positive | 54 | 0 |
| 12 | Mobile app for diabetes self-management | HbA1c | moderate_positive | 54 | 0 |
How to Read Evidence Cards
Every Evidence Card summarizes one intervention-outcome relationship using Dediabetes' Evidence Intelligence system, including overall evidence strength, consistency across studies, evidence profile, supporting study count, and direct access to the underlying evidence.
GLP-1 receptor agonists show strong improvement in HbA1c with consistent results across multiple studies.
Intervention → Outcome. The evidence relationship being summarized.
A plain-language summary of what the evidence suggests.
EvidenceScore™ summarizes the overall strength of the available evidence, considering study quality, quantity, and supporting data.
ConsistencyScore™ summarizes how consistently studies report results in the same direction. Displayed only when enough comparable evidence exists.
Quick indicators describing evidence strength, consistency, effect direction, and evidence topic.
Number of studies contributing to this evidence relationship.
Open the full evidence page for supporting studies, methodology, and related evidence.
EvidenceScore\u2122 and ConsistencyScore\u2122 are generated by the Evidence Intelligence system and are not medical advice.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.